In this article, the authors provide an overview of aquablation, the world's first image-guided, automated, robotically controlled waterjet ablative therapy developed for treating benign prostatic hyperplasia.
Unlike traditional ablative methods, it uses a high-velocity, heat-free saline jet to ablate prostate tissue with minimal damage to surrounding structures. Preserving sexual function, including ejaculatory integrity, is a significant advantage of aquablation. Real-time ultrasound guidance and automated robotics facilitate treatment customization based on the individual, resulting in reproducible outcomes regardless of prostate shape and size. Long-term studies confirm aquablation's durability with sustained symptom relief, improved urinary function, and reduced retreatment rates.
The Urologic clinics of North America. 2025 Aug 25 [Epub]
Lodewikus Petrus Vermeulen, Flavio Vasconcelas Ordones, Amir D Zarrabi, Peter John Gilling
Urology Department, Tauranga Hospital, Auckland University, Tauranga, Bay of Plenty, New Zealand. Electronic address: ., Urology Department, Tauranga Hospital, Auckland University, Tauranga, Bay of Plenty, New Zealand.
PubMed http://www.ncbi.nlm.nih.gov/pubmed/41106982